#FutureReadyHealthcare
Indegene raises awareness and diagnoses rare diseases faster
The Customer
Client is a global pharmaceutical company with a vision to explore new ways to improve and extend people’s lives with commitment to deliver better products. The client wanted to commercialize a molecule for treating auto inflammatory rare-diseases in children, which had little awareness among HCPs and patients
Challenges
Lack of awareness about congenital auto-inflammatory rare disease and its symptoms resulting in slow diagnosis, long patient journeys, and low prescriptions
Inability in identifying right patients due to small patient population
Capture untapped market potential in whitespace to accelerate growth
The Solution
Segmented audience by specialties, discovered therapy areas not covered by client and identified 30,000 potential HCPs to target
Targeted 12,393 high digital affinity HCPs through integrated omnichannel strategy
Developed channel and content mix using insights from Indegene’s proprietary AI powered HCP Smart Profile
Personalized patient journeys created for faster enrollment driven by Indegene NEXT HCP Journey Optimization
Improved awareness that helped identify patients and improve writing behaviors of whitespace HCPs
Outcomes
Increased awareness about rare diseases, symptoms, and faster ways to diagnose through multiple campaigns for HCPs and patients/caregivers
Achieved 38% engagement rate where 497 HCPs showing deeper engagement levels and loyalty
$80 million revenue impact in the span of 2.5 years at 15% cost of sales and marketing
$80 million
Revenue impact in 2.5 years
15%
Cost of sales
12,393
New HCPs identified
